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Abstract  
Evidence on trends in prevalence of disease and disability can clarify whether countries are experiencing a 
compression or expansion of morbidity. An expansion of morbidity, as indicated by disease, has appeared in Europe 
and other developed regions. It is likely that better treatment, preventive measures, and increases in education levels 
have contributed to the declines in mortality and increments in life expectancy. This paper examines whether there 
has been an expansion of morbidity in Catalonia (Spain). It uses trends in mortality and morbidity and links these 
with survival to provide estimates of life expectancy with and without diseases and mobility limitations. We use a 
repeated cross-sectional health survey carried out in 1994 and 2011 for measures of morbidity, and information from 
the Spanish National Statistics Institute for mortality. Our findings show that at age 65 the percentage of life with 
disease increased from 52% to 70% for men, and from 56% to 72% for women; the expectation of life with mobility 
limitations increased from 24% to 30% for men and 40% to 47% for women between 1994 and 2011. These changes 
were attributable to increases in the prevalence of diseases and moderate mobility limitation. Overall, we find an 
expansion of morbidity along the period. Increasing survival among people with diseases can lead to a higher 
prevalence of diseases in the older population. Higher prevalence of health problems can lead to greater pressure on 
the health care system and a growing burden of disease for individuals. 
Keywords: healthy life expectancy, diseases, mobility limitations, Spain. 
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Introduction 
In recent years, researchers have tried to understand whether the ideal of living longer and healthier lives will be 
accomplished. Mortality and morbidity research is crucial to address such a complex issue. Many countries have 
experienced a continuing decline in mortality during the past half-century, influenced by overall reductions among 
older individuals after retirement age (Vaupel et al. 1998; Robine 2011; Janssen and Kunst 2005) with an increasing 
chance of surviving to the fourth age (Baltes and Mayer 1998). In the future, mortality changes at very old ages will 
be compelling due to mortality declines from cardiovascular and respiratory diseases, which are attributable to 
medical prevention, better treatment of diseases, and increases in education levels (Crimmins et al. 2010). However, 
living to older ages has raised the question of how healthy longer life will be. Surprisingly, countries experiencing 
longer lives at very old ages, e.g. southern European countries, do not appear to have better health and they often 
rank among the worst in indicators of disability. For instance, Spain is one of the European countries with the 
longest life expectancy at birth in 2009 (HMD 2013) but the highest levels of functioning problems (Solé-Auró and 
Crimmins 2013), coupled by facing a wave of increasing financial and social costs of long-term care (Alcañiz et al. 
2011). 
Taking into account these demographic and health changes, our work tries to understand whether this long life is 
being accompanied by an increase in time living in good health, examining changes in the prevalence of potentially 
fatal chronic diseases and loss of mobility along with change in mortality in a Mediterranean region of over seven 
million people (Catalonia, Spain). The interest of studying both chronic diseases and mobility functions is to see 
how and when such hazardous health conditions appear in the pathway of human life span, and how long they last 
until death ensues. It is worth noting that having more chronic diseases may cause functional limitations in the 
population. In order to clarify whether there have been changes in the transition from health to disease or mobility 
limitations, we will look at three chronic conditions which can result in death, as well as mobility limitations, and 
link these with mortality. Hence, we will provide estimates of life expectancy with and without these conditions 
during the last two decades. In the following sections we summarize the recent general trends in health, morbidity, 
disability and mortality, paying special attention to Spain. We begin with a discussion of the dynamics of health to 
see whether there is a redistribution of disease and disability in the later stages of life. Afterwards, we study trends 
in major diseases and mobility limitations, and we estimate healthy life expectancies linked to disease and disability. 
In the end, our main aim is to investigate the implications of changes in the prevalence of conditions on the length of 
life with and without disease and mobility limitations in the life table population. 
The dynamics of health at old ages 
As Gruenberg (1977), Manton (1982) and Fries (1980) pointed out thirty years ago, mortality declines at older ages 
could be due to: 1) an expansion of morbidity (people live longer, but less healthy), 2) a compression of morbidity 
(death is delayed, disease starts later), or 3) a dynamic equilibrium between increased prevalence of disability and a 
reduction in its severity. These three theories have contributed to the development of further research on health 
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trends (Robine and Michel 2004) and are important for service planning, since the three imply quite different 
pressures on health systems and services.  
The optimistic point of view of aging proposed by Fries (1980), a compression of morbidity, pointed out that 
morbidity is compressed into a shorter period before death, increasing the proportion of life free of disease. There is 
now an open debate about this theory within a large body of research in demography, epidemiology and public 
health. In the 1990s, an increase in life expectancy was accompanied in most countries by an increase in time lived 
without disability (Cai and Lubitz 2007) or moderate limitations (Graham et al. 2004), indicating a dynamic 
equilibrium, as only a small delay in the onset was found. In the early 2000s, a continuation of the dynamic 
equilibrium of the 1990s (Cheung and Yip 2010; Galenkamp et al. 2012), and an emerging expansion in some forms 
of severe disability in the older populations were observed (Hashimoto et al. 2010). Thus, there was an expansion of 
morbidity in the late 1990s and early 2000s as the prevalence of chronic diseases and some risk factors appear to 
have been increasing in both Europe and other developed regions (Gutiérrez-Fisac et al. 2002; Crimmins and 
Beltrán-Sánchez 2011). Spain, like other countries (Freedman et al. 2004; Cambois et al. 2008), experienced a 
compression of disability since the 1980s (Sagardui-Villamor et al. 2005). However, for diseases, most prevalences 
in the Spanish population have risen until advanced ages (Martínez-Beneyto et al. 2011). Further investigation will 
provide evidence on survival and morbidity trends in Spain. 
Trends in diseases 
At the beginning of the past century, infectious diseases accounted for the majority of deaths, but now chronic 
diseases dominate. Due to medical improvements people often live with diagnosed diseases for long periods of time. 
Cardiovascular disease (CVD) is a major health problem across the world and is now responsible for approximately 
one-third of the deaths in both developing and developed countries (Deaton et al. 2011). CVD among European 
populations is mainly attributable to classical risk factors such as diets high in saturated fats, elevated cholesterol, 
hypertension, diabetes, smoking and sedentary lifestyle. However, it is important to notice that developed countries 
have enjoyed substantial mortality declines in CVD (O'Flaherty et al. 2013; Bhatnagar et al. 2011). Within Europe, 
southern European countries are better off in terms of CVD mortality risk than those in the north. CVD in Spain has 
also experienced a downward trend (Ruiz-Ramos et al. 2008), and it now represents the second lowest coronary 
mortality rate in Europe after France (Sans et al. 1997). 
Hypertension is one of the most prevalent universal risk factors, especially in patients with established CVD, 
and accounts for 6% of deaths worldwide (Murray and Lopez 1997). Around 11% of all disease burden in developed 
countries and about a quarter of European heart attacks are due to hypertension, while hypertensive individuals have 
twice the risk of experiencing heart attack compared to those without a history of hypertension (Nichols et al. 2012). 
The treatment of hypertension has improved dramatically over the past decades, contributing to the reductions of 
mortality incidence due to CVD. In Spain, substantial efforts have been made to diminish hypertension rates 
(Llisterri et al. 2012); however, the treatment strategy adopted has not been enough to slow down the increases 
through the last decade (Cordero et al. 2011). 
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Diabetes is another chronic disease that substantially contributes to increase the risk of CVD, and also 
magnifies the effect of other risk factors (high cholesterol levels, raised blood pressure, smoking and obesity). 
People with diagnosed diabetes have three times the risk of a heart attack compared to those without (Nichols et al. 
2012). Diabetes trends in Europe are alarming, given the notable increase in prevalence in most countries (Passa 
2002). Spain is not an exception and diabetes has become an important public health problem because of its growing 
magnitude and its impact on CVD (Ruiz-Ramos et al. 2006). A combination of several factors, such as changes in 
the diagnostic criteria for diabetes, population aging, and lower mortality among persons with diabetes, has led to an 
increase in disease prevalence (Valdés et al. 2007).  
Disability and physical functioning trends 
The first studies on disability appeared in the late 1960s and 1970s with a general conclusion that disability did not 
decrease during this time period (Wilmoth 1997; Kaplan 1991; Crimmins et al. 1997). Later on disability declines 
were reported, particularly for the older population and during the 1980s, in developed countries like Japan, the 
United States, or France (Jacobzone et al. 1999; Robine et al. 2002). In the 1990s, the worldwide rates of disability 
indicated a dynamic equilibrium between prevalence and severity (Parker and Thorslund 2007; Moe and Hagen 
2011; Crimmins et al. 2009), and mixed patterns have appeared in recent years. The disability distribution within 
Europe is not uniform. Some European countries have shown an expansion of disability among mid-adults (Cambois 
et al. 2012; Lafortune et al. 2007), while other countries, like the Netherlands, have experienced high and stable 
prevalence of disability. However, disability rates are expected to increase in the future due to the aging of the 
population (Picavet and Hoeymans 2002). Southern Europeans are expected to spend a higher percentage of their 
lives with disability compared to the people from the north (Minicuci et al. 2004). Nevertheless, Spain experienced a 
compression of disability and the postponement of severe disability onset to more advanced ages from the 1980s to 
the present (Zunzunegui et al. 2006; Sagardui-Villamor et al. 2005). 
In the progressive deterioration of health, the mobility limitations that people suffer at old ages are an anticipated 
stage before the development of disability. The trends in prevalence of functioning problems in the U.S. show 
reduced functioning ability of people approaching old ages in the early 2000s (Martin et al. 2010; Lakdawalla et al. 
2004). These results contrast unfavorably with the ones obtained two decades ago, particularly in the U.S., when 
research showed improvements in physical functioning problems in the 1990s (Crimmins 2004). However, there is a 
less clear worldwide pattern between the 1990s and 2000s. For instance, in the 1990s, increasing functional 
limitations were found for England, while reduced prevalences appeared among older Norwegians, and stable rates 
were seen in the Netherlands (Moe and Hagen 2011; Martin et al. 2012; Hoeymans et al. 2012). Knowing these 
trends is crucial, because an increase in the number of older persons may raise the demand for health care services, 
whereas decreasing prevalences of functional limitation among them may counteract this demographic effect. 
Methodology 
Data 
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We used data obtained between 1994 and 2012 from the Catalan Health Survey (ESCA) (Generalitat de Catalunya 
2013). The Department of Health in Catalonia (Spain) – a highly populated Mediterranean region located in the 
northeast corner of the Iberian Peninsula – is responsible for the technical execution of the survey. The ESCA is the 
only source of micro data for Catalonia, containing information on morbidity in relation with socio-demographic 
variables, health behaviors and individual’s state of health. The sample follows a stratified design, based on age, 
gender and geographical area. The random collection of the data is performed using personal interviews. The 
questionnaires of each time-period are designed to be comparable. 
This cross-sectional survey was collected in 1994 and continuously during the period 2010 to 2012 (Alcañiz et 
al. 2014). In the last time period we combined data of the last three year’s available (2010, 2011 and 2012) to 
increase our sample size, and considered 2011 our midpoint year. Hence, when we refer to the year 2011 in our 
analysis, we include data from the years 2010, 2011 and 2012. Our sample is comprised of 20,433 Catalan non-
institutionalized residents (12,584 people in 1994 and 7,849 people in 2011) randomly selected aged 15 years and 
older. Because mortality is not appended to the ESCA, mortality information came from the official life tables from 
the Spanish National Statistics Institute database (INE 2012).  
Measures 
We use three indicators of the presence of potentially fatal chronic diseases: hypertension, diabetes and heart 
disease. Similar question wording is reported in the two time periods in response to the question: “Do you have or 
has a doctor ever told you that you have any of the following conditions…?”, followed by a list of chronic medical 
disorders including hypertension, diabetes and heart disease.  
In this survey, people also reported whether they had difficulties or limitations in performing a set of mobility 
functions. We have chosen an indicator of mobility limitations based on a positive answer (yes versus no) to at least 
one of these three items: 1) mobility problems, such as the inability to move out of the house without receiving help 
from another person, 2) walking problems, that may require using special equipment, and 3) other important 
mobility limitations, such as the difficulty to walk up and down a flight of stairs, and standing, without using special 
equipment.  
Statistical analyses 
We first examine recent changes in the prevalence of diseases, which are prominent causes of mortality at older 
ages, and the presence of mobility limitations. Healthy life expectancy is estimated using the Sullivan approach 
(Sullivan 1971), a prevalence-based method of dividing life-table years lived in an age interval, into years with and 
without health disorders, based on the specific health prevalence of that age group. We also show 95% confidence 
intervals for estimated life expectancy with and without diseases (Jagger 1999). Error margins are constructed based 
on statistical sampling analysis (Kish 1995; Levy and Lemeshow 1991). If we set a 95% confidence level, estimated 
sampling errors are around ±3% for all percentages, except for ages 80-plus, where samples are smaller and the 
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errors range between ±5% and ±7%. Using the healthy life expectancy calculations, we estimate the expected age 
that chronic diseases or mobility limitations appear in life by gender in each time period. Analyses were conducted 
using Stata software, version 12 (StataCorp). 
Results 
Trends in prevalences of diseases and functional limitations  
Table 1 shows the percentages of people with hypertension, diabetes and heart disease, and ensuing mobility 
limitations. Results are stratified by age groups and gender over time.  
[Insert Table 1 about here] 
Prevalence of hypertension increased over time, with clear gender differences. For men, prevalence of 
hypertension increased in the almost two-decade time period, except at younger ages (15-39) where rates are low 
and differences between periods are not statistically significant. After age 60, increase in the percentage of males 
with hypertension is similar over time. This is not the case for women, who survived longer with diseases, and show 
significant increases after age 60 over time. Diabetes is our second chronic disease and increases are generally seen 
over time. These increments are statistically significant after age 50 for males and only in the oldest ages for females 
(80-plus). Diabetes rates diminished for both genders after age 70 up to 1994. This is not the case in recent dates, 
where prevalence for men is steady after age 70, and even grows for women. Our third health condition is heart 
disease. In both periods, the prevalence of heart disease rises as individuals get older. Among men aged 70-plus, 
increases of heart disease prevalences are noticed in the two-decade period, while this trend is not so clear for 
women. Women rates of heart disease are quite similar over time, with significant increases only after age 80.  
Table 1 concludes with our mobility measure. Men and women aged 70-plus experience increments in the 
prevalence of mobility problems between 1994 and 2011. Larger increments are seen in the oldest age (80-plus). 
Higher prevalences of mobility limitations are found for women than for men almost at all ages over time.  
Changes in healthy life expectancy: 1994-2011 
Few analyses on healthy life expectancy in Spain or other Mediterranean countries have examined changes in life 
expectancy with disease or mobility limitations (Sagardui-Villamor et al. 2005). Figure 1 shows the increase in 
overall survival between 1994 and 2011. This curve indicates a rise in survival time over these years, so people are 
expected to live longer now than two decades ago. Figure 1 also shows the curves representing survival without 
mobility limitations and without diseases over time. For both genders survival curves without diseases are shifted 
leftward, indicating less time surviving without diseases. A particularity for women between ages 45 and 55 is seen 
as curves show more time surviving without diseases in recent periods. Survival curves without disease are much 
more linear than those for mobility limitations or full life, especially after age 40. This steady negative slope in the 
survival curve without diseases indicates that the onset of diseases after age 40 is not as concentrated in older ages 
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as is death. It is worth noting that survival curves without mobility limitations are closer to overall curves - more for 
men than for women -, showing that females spend a longer period of their late life with mobility problems. The 
curves indicating survival without mobility limitations are above those representing survival without diseases, 
meaning that mobility limitations occur at older ages than the diseases we consider. 
[Insert Figure 1 about here] 
Table 2 gives the values of the expected lifetime with and without diseases and mobility limitations over time at 
15 and 65 years of age. Confidence intervals are shown and due to large sample sizes their precision is quite good 
(hardly exceeding 1 year around the healthy life expectancy). Life expectancy increases along the whole period, 
showing faster increments in younger cohorts. At age 15, life expectancy increased 4.6 years for men and 3.2 years 
for women; at age 65, both genders show the same gain in life expectancy (2.5 years).  
[Insert Table 2 about here] 
Over time, men aged 65 experienced increments of life expectancy with disease (4.5 years), and consequently a 
decrease of years without disease (2 years). If we compare increases in men’s overall life expectancy with decreases 
in men’s life expectancy without disease, we observe an expansion of morbidity: men live longer but the onset of 
disease is earlier. This trend is also true for women. This expansion can be easily seen when we look at the 
percentage of life spent with disease over time: at age 65, this percentage goes from 52% to 70% for men and from 
56% to 72% for women. Similar patterns are observed at age 15.  
In recent times we also see different patterns on the gender gap in life expectancy with diseases. Table 3 
presents the expected age that the health disorders examined here appear by gender over time. For instance, in 2011, 
15-year-old men will suffer from these diseases a third of their life, starting, on average, at age 58.1; the same 
portion of men’s life with diseases is identified for women, but they will start suffering from the diseases considered 
here later in life as they live longer (age 61.6). Therefore, 3.5 years was the gender difference in 2011; but only 1.4 
years in 1994 (starting at age 62.1 for men and 63.5 for women). This gender gap decreases, but does not vanish, at 
older ages: 1.1 years in 1994, and only a scarcely significant 0.6 years in 2011. At older ages women’s health 
declines more sharply than men’s and the gap between genders fades out. 
[Insert Table 3 about here] 
Temporal patterns for mobility limitations are slightly different. At 65 the percentage of life with functioning 
problems has risen from 24% to 30% for men, and from 40% to 47% for women from 1994 to 2011. On average 
men aged 65 in 1994 have experienced mobility problems at 77.3 years; in 2011 this activity limitation appears at 
78.0, and women at age 65 have suffered mobility problems at 77.1 in both years (Table 3). Therefore, the ages of 
onset of impairment are very similar, which denotes no relevant gender difference concerning life expectancy 
without mobility limitations over time.  
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Discussion 
Regarding the health of the population in Catalonia (Spain), we found that mobility limitations occur later in life 
than the potentially fatal diseases studied. These chronic diseases arrive earlier for men than women, while the onset 
of mobility limitations for those who were able to function at 65 appears at a similar age by gender at both time 
periods. Specifically, the prevalence of hypertension increases over time, although part of these increments may be 
due to better health surveillance that makes people aware of the conditions they have (Howard et al. 2010). 
Concerning diabetes the fact that in recent dates prevalences do not decrease at old ages suggests that better 
monitoring and treatment have succeeded in avoiding premature death due to health complications caused by this 
disorder for both genders (Valdés et al. 2007). Prevalence of heart disease increases until very old ages over time, 
which may be a result of early detection plans, or a consequence of longer survival due to better treatment. Part of 
the gender differences in the prevalence of heart disease may be explained, as pointed out by Flink et al. (2013), by 
the fact that women are less likely to know the symptoms of heart failure, which may delay requesting the medical 
services until life is already seriously compromised. Because life expectancy is longer for women than men, women 
will spend a higher portion of their lives with both chronic diseases and mobility limitations.  
Our findings reveal an outstanding expansion of potentially fatal diseases along the period at the oldest age, as 
people live almost 5 years longer with diseases in 2011 than at the beginning of the 1990s. This expansion is 
attributable to both a longer life (mostly for women), and an earlier onset of diseases (especially for men), which 
translates to higher incidence as pointed out by Solé-Auró et al. (2013) in some European countries. Increasing 
survival among people with diseases has led to a higher prevalence of diseases in the Catalan population. Our results 
may be picking up not only a higher risk of illness at younger ages, but an improvement in early control and 
diagnosis of diseases, particularly hypertension and diabetes, over the years. Due to the earlier onset of disease in the 
lifetime, individuals affected are not only the oldest, but also working age people. It is likely that the rise in the 
prevalence of health disorders, particularly heart disease, is mainly explained by better knowledge and treatment of 
the diseases, increased contacts with medical doctors, and screening campaigns (Ford et al. 2007; Yang et al. 2012). 
Either way, a scenario of a higher prevalence of diagnosed health problems and longer disease-specific survival can 
lead to a greater pressure on the health care system, compounded by the fact that in Spain this system is universal 
and provides appropriate basic health care coverage for all. This effect is lessened taking into account that early 
diagnosis helps prevent the arrival of advanced stages of the disease that often imply substantial medical expenses. 
In addition, regarding individual quality of life, a timely diagnosis usually implies medical care, which can extend 
life in relatively good health, or at least lead to less severe illness. In sum, disease expands, although we cannot 
assert that quality of life deteriorates. It may be an effect of decreased severity as a consequence of better monitoring 
of diseases, which would partially explain the increase of the proportion of years with disease. Concerning mobility 
limitations, little expansion between 1994 and 2011 is found for men and women at age 65, mainly caused by the 
increments in life expectancy and not by an earlier detection. Nevertheless, the growth on the demand of health care 
is not necessarily smaller than for diseases, because the expenses incurred depend on the severity of the disorders 
and need for care.  
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Gender differences are also relevant during this time period. Our results show an expansion of the gender gap in 
life expectancy with diseases at younger ages, but decreases at older ages over time. If the gender gap keeps 
decreasing at older ages, it may suggest that the mortality advantage of women is influenced by lower prevalence of 
the diseases we consider in earlier stages in the life cycle. The literature states several causes for these gender 
differences, such as hormonal differences (Pérez-López et al. 2010). In any case, it has to be taken into account that 
these results could change if we studied other diseases, such as cancer. Concerning mobility limitations, no relevant 
changes in gender difference appear over time.   
Despite the Spanish advantageous position in CVD mortality rates within Europe, if we want a more healthy 
society with fewer diseases concentrated at the end of our life, it is important to work on prevention. The strong 
interrelation among hypertension, diabetes and heart disease contributes to increased risk of cardiovascular problems 
and magnifies the effect of several risk factors, such as smoking or obesity (Nichols et al. 2012). Much of the CVD 
burden worldwide is avoidable, but demands a global approach to prevention (Deaton et al. 2011). For instance, 
there is a wide field for preventive measures of diabetes and hypertension beginning with simple strategies of 
primary care, such as the control of body mass index (Lee et al. 2012). Thus, a good control of hypertension is 
relatively easy to achieve through a healthy lifestyle accompanied by medication in severe cases (Llisterri et al. 
2012). Deterioration in mobility associated with old age could be delayed by educating people from youth about the 
benefits of a regular practice of physical exercise. Further thoughts are necessary on how to improve the key 
modifiable lifestyles or behavioral risk factors for CVD and functioning loss - smoking, dietary intake, and physical 
activity (WHO 2009). In fact, any improvement in the prevention or treatment of one of these potentially fatal 
diseases will have an overall positive effect over the individual health, and therefore over society as a whole.  
There are some limitations to the present study that should be noted here. The investigation of disease incidence 
and longer survival with adverse health conditions would provide clarity, but no longitudinal data for Spain are 
available. The ESCA does not provide any indicator of disease severity, so we can not assert that quality of life 
related to health has been diminished. Cancer is another important disease to take into account, but our survey does 
not provide such information in the first year of our analysis. Moreover, since the institutionalized population is not 
included in our analysis due to lack of data, our findings apply only to the community-dwelling population. While it 
is often hard to find data on institutionalized population by age, in 2006 the Catalan health authority reported that 
0.7% of the population lived in institutions (Generalitat de Catalunya, 2006). The inclusion of this population might 
result in a slight increase of the prevalence rates for the Catalan population (Lobo et al. 2007); however, it is 
unlikely that this would be sufficient to change the direction of our findings. While we recognize these limitations, 
we believe that the analysis presented here is an important step in understanding the trends and dynamics in healthy 
life expectancy for almost the last two decades in a Mediterranean region. 
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